SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-016818
Filing Date
2024-05-15
Accepted
2024-05-15 09:01:25
Documents
16
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20240113_8k.htm   iXBRL 8-K 25444
2 EXHIBIT 99.1 ex_615116.htm EX-99.1 71786
7 atxilogo.jpg GRAPHIC 15219
  Complete submission text file 0001437749-24-016818.txt   254865

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240515.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240515_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240515_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240515_pre.xml EX-101.PRE 11585
19 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240113_8k_htm.xml XML 2847
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 24947487
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)